TME Pharma N.V. Tangible Net Worth Ratio
TME Pharma N.V. tangible net worth ratio. TME Pharma N.V. (ALTME) has a Tangible Net Worth Ratio of 99.8% as of December 2024. This metric is calculated by deducting intangible assets (€4.00K) from net assets (€1.61 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check TME Pharma N.V. (ALTME) strategic investment index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of TME Pharma N.V. (2020–2024)
Tangible net worth ratio of TME Pharma N.V. from 2020 to 2024. This chart shows how TME Pharma N.V.'s Tangible Net Worth Ratio has changed across 3 annual periods from 2020 to 2024. As of December 2024, the ratio stands at 99.8%, reflecting net assets of €1.61 Million with intangible assets of €4.00K EUR. See ALTME working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
TME Pharma N.V. Tangible Net Worth Ratio by Year (2020–2024)
TME Pharma N.V. tangible net worth ratio by year from 2020 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for TME Pharma N.V. from 2020 to 2024, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of TME Pharma N.V..
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 99.8% | €1.61 Million | €4.00K | €3.41 Million | ▼ -0.2 pp |
| 2021 | 99.9% | €4.50 Million | €4.00K | €9.77 Million | ▼ 0.0 pp |
| 2020 | 99.9% | €7.70 Million | €4.00K | €10.65 Million | — |